Drug Testing Locations - Montezuma, CO

Drug Testing in Montezuma, CO

Montezuma, Colorado Statistics

In Montezuma, CO, located in Montezuma County, 15% of high school students reported misusing prescription drugs in 2021.

Montezuma County witnessed a 7% increase in opioid-related hospital admissions from 2019 to 2022.

In 2022, 11% of Montezuma, CO adults reported using marijuana more than three times a week.

Montezuma County had the third-highest rate of methamphetamine-related arrests in Colorado in 2021.

From 2020 to 2022, there was a 10% increase in drug-related emergency room visits in Montezuma, CO.

Alcohol-related incidents accounted for 22% of all substance abuse cases in Montezuma County in 2021.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Montezuma, CO & Drug Testing Policies

Employers in Montezuma, CO, are increasingly implementing drug testing policies to maintain a safe and productive workplace. Many local businesses have adopted policies that include pre-employment screening, as well as random and post-accident testing. These measures are in line with guidance from the U.S. Department of Labor, which encourages employers to ensure a drug-free workplace.

Some organizations collaborate with occupational health services to conduct testing, which helps deter substance use among employees. Moreover, Montezuma employers often provide support through Employee Assistance Programs (EAPs), which offer counseling and recovery resources. These initiatives help employees address substance abuse challenges and promote overall well-being and productivity in the workplace. Compliance with state and federal regulations ensures that testing procedures respect privacy and labor rights.

Government Efforts with Drug Problems in Montezuma, CO

The government in Montezuma, CO, has taken significant steps to combat drug abuse through local initiatives and partnerships. Various programs have been implemented to support prevention and treatment efforts, and Montezuma County has been actively working with state agencies like the Colorado Department of Human Services. Collaborative efforts with the Substance Abuse and Mental Health Services Administration (SAMHSA) aim to reduce the impact of substance abuse by offering resources and establishing community support networks.

In addition, Montezuma County law enforcement collaborates with federal agencies to address trafficking and distribution issues. Government grants have facilitated the establishment of drug-free community programs and the development of local rehabilitation facilities. Educational campaigns targeting young people have been launched to raise awareness about the risks of drug abuse. These combined efforts aim to create a safer environment and support individuals in their recovery journey.

Local Drug Busts & News in Montezuma, CO

Recent drug busts in Montezuma, CO have showcased the efforts of local law enforcement in curbing illicit drug activities. In a coordinated operation with the Drug Enforcement Administration (DEA), Montezuma County authorities dismantled a major methamphetamine distribution ring in early 2023. This operation resulted in multiple arrests and the seizure of significant quantities of drugs, weapons, and cash.

In another notable event, a multi-agency task force successfully apprehended individuals involved in a prescription drug trafficking network spanning several counties. This joint effort underscores the importance of inter-agency collaboration in addressing drug-related issues. Public awareness events are also organized, aiming to educate the community about the dangers of drug abuse and the legal consequences associated with involvement in such activities.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Montezuma, CO. Trusted by employers nationwide for accurate results and exceptional service.

Colorado DOT/Non DOT Physicals

Colorado Vision Tests

Colorado Audiograms

Colorado Respirator Fit Tests

Colorado Lift Tests

Colorado Background Checks

Clinical Testing Services

TB Testing in CO

Diabetes Testing in CO

Infectious Disease Testing in CO

Sickle Cell Anemia Testing in CO

Women/Men's Health Testing in CO

Resources & Citations

Colorado Department of Human Services

Substance Abuse and Mental Health Services Administration (SAMHSA)

Crossroads Cortez

Signal Behavioral Health Network

Therapists in Cortez, CO

Axis Health System

Working Partners

4th Judicial District Drug Court

The National Child Advocacy Center

Ignite Centers

Drug Testing Near Montezuma, CO

Durango, CO

Dove Creek, CO

Hesperus, CO

Marvel, CO

Kline, CO

Mayday, CO

Redmesa, CO

Cahone, CO

Stoner, CO

Mancos, CO

Yellow Jacket, CO

Ute Mountain, CO

Dolores, CO

Towaoc, CO

Cortez, CO

Frequently Asked Questions

Customer Reviews